By Charlie Alovisetti, Genevieve Meehan, Josh Kappel
May 27, 2022
Do commercial opportunities for entrepreneurs exist in psychedelics? We explore the current limited legal pathways and potential opportunities via proposed legislation and ballot initiatives in this article.
By Meg Nash
May 26, 2022
After years of debate, Rhode Island legalized cannabis for adult use. Read this for key provisions of the "Rhode Island Cannabis Act."
By Charlie Alovisetti, Navid Brewster
May 10, 2022
Raising money for a company is challenging. It can be even more challenging if you haven’t been through the process before and don’t know what decisions you need to make. This article lays out 10 key considerations to think about when setting up your financing.
By Andrea Golan
May 6, 2022
CDPH published proposed emergency regulations detailing the registration requirements and annual fees for manufacturers of hemp extract and hemp products. CDPH is accepting public comments through May 31, 2022.
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.